Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth, Hanover, New Hampshire, USA.
Louis V Gerstner Jr. Graduate School of Biomedical Sciences, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
mSphere. 2023 Dec 20;8(6):e0030523. doi: 10.1128/msphere.00305-23. Epub 2023 Oct 12.
can cause a life-threatening infection known as invasive pulmonary aspergillosis (IPA), which is marked by fungus-attributable mortality rates of 20%-30%. Individuals at risk for IPA harbor genetic mutations or incur pharmacologic defects that impair myeloid cell numbers and/or function, exemplified by bone marrow transplant recipients, patients that receive corticosteroid therapy, or patients with chronic granulomatous disease (CGD). However, treatments for infections remain limited, and resistance to the few existing drug classes is emerging. Recently, the World Health Organization classified as a critical priority fungal pathogen. Our cell death research identifies an important aspect of fungal biology that impacts susceptibility to leukocyte killing. Furthering our understanding of mechanisms that mediate the outcome of fungal-leukocyte interactions will increase our understanding of both the underlying fungal biology governing cell death and innate immune evasion strategies utilized during mammalian infection pathogenesis. Consequently, our studies are a critical step toward leveraging these mechanisms for novel therapeutic advances.
可引起一种危及生命的肺部感染,称为侵袭性肺曲霉病(IPA),其特征是真菌感染死亡率为 20%-30%。IPA 风险人群存在基因突变或药物缺陷,导致髓样细胞数量和/或功能受损,骨髓移植受者、接受皮质类固醇治疗的患者或慢性肉芽肿病(CGD)患者就是典型代表。然而,IPA 的治疗方法仍然有限,而且对少数现有药物类别的耐药性正在出现。最近,世界卫生组织将其列为一种关键优先真菌病原体。我们的细胞死亡研究确定了一个影响白细胞杀伤易感性的真菌生物学的重要方面。深入了解介导真菌-白细胞相互作用结果的机制将增加我们对控制细胞死亡的基础真菌生物学和哺乳动物感染发病机制中先天免疫逃避策略的理解。因此,我们的研究是朝着利用这些机制取得新的治疗进展迈出的关键一步。